Clinically Approved Drugs Inhibit the Staphylococcus aureus Multidrug NorA Efflux Pump and Reduce Biofilm Formation

Staphylococcus aureus has acquired resistance to antibiotics since their first use. The S. aureus protein NorA, an efflux pump belonging to the major facilitator superfamily (MFS), contributes to resistance to fluoroquinolones (e.g., ciprofloxacin), biocides, dyes, quaternary ammonium compounds, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmermann, Saskia, Klinger-Strobel, Mareike, Bohnert, Jürgen A., Wendler, Sindy, Rödel, Jürgen, Pletz, Mathias W., Löffler, Bettina, Tuchscherr, Lorena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901667/
https://www.ncbi.nlm.nih.gov/pubmed/31849901
http://dx.doi.org/10.3389/fmicb.2019.02762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901667/
https://www.ncbi.nlm.nih.gov/pubmed/31849901
http://dx.doi.org/10.3389/fmicb.2019.02762

Ejemplares similares